A high-quality NMR solution structure is presented for protein hMcl-1(171-327) which comprises residues 171-327 of the human anti-apoptotic protein Mcl-1 (hMcl-1). Since this construct contains the three Bcl-2 homology (BH) sequence motifs which participate in forming a binding site for inhibitors of hMcl-1, it is deemed to be crucial for structure-based design of novel anti-cancer drugs blocking the Mcl1 related anti-apoptotic pathway. While the coordinates of an NMR solution structure for a corresponding construct of the mouse homologue (mMcl-1) are publicly available, our structure is the first atomic resolution structure reported for the 'apo form' of the human protein. Comparison of the two structures reveals that hMcl-1(171-327) exhibits a somewhat wider ligand/inhibitor binding groove as well as a different charge distribution within the BH3 binding groove. These findings strongly suggest that the availability of the human structure is of critical importance to support future design of cancer drugs.
Introduction
The malfunctioning of cellular apoptosis [1] is a major hallmark of cancer. The regulation of apoptosis depends on the family of Bcl-2 proteins which contain one or several Bcl-2 homology (BH) sequence motifs. Based on their function and the similarity of their respective BH sequence motifs, these proteins can be grouped into three classes [2] , [3] : (i) multi-domain pro-apoptotic proteins such as Bax and Bak, (ii) anti-apoptotic (i.e., pro-survival) proteins such as Mcl-1, Bcl-1, Bcl-x L , Bcl-w and Bfl-1/A1, all of which exhibit a similar architecture as Bax and Bak, and (iii) several pro-apoptotic proteins comprising only a single BH3 sequence motif such as Bid, Bad, Bim, Puma, Noxa, Hrk, Bmf, and Nbk/Bik ('BH3-only' proteins). The BH3 motif of class (iii) proteins forms an amphipathic a-helix which interacts specifically with a hydrophobic pocket formed in both pro-apoptotic class (i), and antiapoptotic class (ii) proteins with participation of their respective BH motifs [2] , [3] . Inhibition of the resulting protein-protein complex formation offers a promising strategy to treat cancer. For example, the small molecule Bcl-2 antagonist ABT-737 [4] inhibits anti-apoptotic class (ii) proteins Bcl-x L , Bcl-w and Bcl-1, and a congener [5] that can be orally administered is currently in clinical trials.
The anti-apoptotic, pro-survival 350-residue protein Mcl-1 ('myeloid cell leukemia-1') [2] is primarily anchored in the outer mitochondrial membrane by a C-terminal trans-membrane domain and contains three BH sequence domains: BH3 (residues 209-223), BH1 (252-272) and BH2 (residues 304-319) [2] . Mcl-1 inhibits death receptor-induced apoptosis by selectively binding to truncated Bid (tBid) [6] and can sequester endogenous Bak to block Bak-mediated cell death. Moreover, Mcl-1 interacts with several BH3-only proteins (Bim, Bid and Puma, Noxa and Bak). Hence, Mcl-1 plays an early role in response to signals directing either cell survival or cell death [2] and has been shown to be upregulated in numerous malignant tumors. Approaches abrogating the Mcl-1's anti-aptototic function either by reducing its abundance or by inactivating its functional BH3-binding groove show great promise for the cancer treatment [2] , [4] , [6] , [7] . Here we present the high-quality NMR solution structure of polypeptide segment 171-327 of human Mcl-1 (hMcl-1) which comprises the three BH motifs deemed to be crucial for structure based drug design.
Results and Discussion
A high-quality NMR structure of hMcl-1(171-327) was obtained (Table 1 ) and the coordinates were deposited in the PDB [8] (accession code 2mhs). The structure comprises seven ahelices a1-a7 (residues 173-191, 204-235, 240-253, 262-280, 284-301, 303-308 and 311-319) arranged to form the characteristic 'Bcl-2 core' structure [9] (Figure 1 ). The helices are locally and globally well-defined, while the C-terminus (residues 320-327) and the loops connecting, respectively, helices a1 and a2, helices a3 and a4, and helices a4 and a5 are flexibly disordered. The central helix a4 is surrounded by the other six helices, with a1, a2, a3 and a5 packed around one side, and a6 and a7 packed against its N-terminus. Helices a2, a3, a4 and a7 participate in forming the BH3 binding groove. The electrostatic protein surface potential is positive at both ends of the BH3 binding groove (due to the presence of Arg 233, Lys 234, Arg 248 and Arg 263) and negative at the side of helix a3 side (due to Asp 256) ( Figure 2 ). This shows that the charge distribution in the BH3 binding groove of hMcl-1(171-327) differs distinctly from other anti-apoptotic proteins [10] .
Including our hMcl-1(171-327) structure, twenty atomic resolution structures containing different Mcl-1 constructs are currently deposited in the PDB. In addition to the two 'apo' proteins hMcl-1(171-327) and mouse mMcl-1(152-308) [10] [PDB accession code 1wsx, 89% sequence identity with the human protein], the structures for nineteen protein-ligand complexes were deposited (Table 2 ) [9] , [11] [12] [13] [14] [15] [16] [17] [18] . Clearly, the large number of available structures reflects the outstanding interest in Mcl-1 as a target for the development of new cancer drugs. Superposition of the a-helices reveals, as expected, close structural similarity for all Mcl-1 proteins structures (Figure 3 ): the root mean square deviation (rmsd) values range from 1.05 to 1.54 Å relative to hMcl1-1(171-327) ( Table 2 ). However, comparison of the two apo protein structures of hMcl-1(171-327) and mMcl-1(152-308) with the complex structures shows that the binding pocket is widened upon complex formation (Table 2) : the distances between the C a -atoms of residues His 224 in helix a2 (His 205 in mMcl-1) and His 252 (His 233 in mMcl-1) at the Cterminus of helix a3 are, respectively, ,16 Å and ,14 Å in hMcl-1(171-327) and mMcl-1(152-308), and ,18-21 Å in the complexes.
The fact that the human apo protein exhibits a somewhat wider binding groove than the mouse homologue (Table 2) can be, at least partially, ascribed to the side chain of Leu 246 in the human protein which is not buried as deeply as the corresponding Phe side chain in the mouse protein. Furthermore, when comparing the human and the mouse protein, differences are observed for the charge distributions in the BH3-binding groove ( Figure 2 ): the human protein is negatively charged on the side of helix a3, while the corresponding surface of mouse protein is positively charged. This difference arises from Ser 255 corresponding to Lys 236 in the mouse protein. Remarkably, hMcl-1(171-327) is structurally more similar to the hMcl1(171-327)-hBim BH3 complex ( Figure 3 ) than to apo mMcl-1(152-308) ( Table 2) .
Taken together, structural comparisons show that, in spite of the 89% sequence identity between human and mouse protein, the availability of the human hMcl-1(171-327) structure can be expected to be of critical importance for supporting future design of cancer drugs.
Materials and Methods

NMR Sample Preparation
Preliminary studies showed that hMcl-1(171-327) (UniProtKB/ Swiss-Prot ID Q07820/MCL1_HUMAN) is not stable in solution. However, the mutant Cys 286 R Ser is stable for several weeks at concentrations ,0.7 mM, and both wild-type and mutant bind the Bim-BH3 peptide with the same affinity (K d , 60 pM) in a Biacore assay. Hence, we solved the NMR structure of hMcl-1(171-327) Cys 286 R Ser referred to as hMcl-1(171-327) in this publication.
hMcl-1(171-327) was cloned, expressed, refolded and purified following standard protocols to produce a uniformly 13 C, 15 Nlabeled protein sample [19] . Briefly, the gene was cloned into a pET21d (Novagen) derivative yielding plasmid pSR482-21.1. The resulting construct contains seven nonnative residues at the C- 171-327) . a-helices a1-a7 are labeled and colored differently, and the N-and C-termini are labeled as ''N' '' and ''C' ''. The figures were generated using the programs MOLMOL [36] and PYMOL [37] . doi:10.1371/journal.pone.0096521.g001 terminus (LHHHHHH) to facilitate protein purification. Escherichia Coli BL21 (DE3) pMGK cells, a codon enhanced strain, were transformed with pMcl1-21.1, and cultured in MJ9 minimal medium [20] containing ( 15 NH 4 ) 2 SO 4 and U-
13
C-glucose as sole nitrogen and carbon sources. Double-washed inclusion bodies containing hMcl-1(171-327) were solubilized in 8 M buffered guanidine hydrochloride (VWR) containing 5 mM DTT, slowly diluted into nine volumes of 20 mM Tris-HCl, 250 mM NaCl, 0.5 M urea, 10% glycerol, pH 7.4, and refolded within 72 hours at 4uC. hMcl-1(171-327) was purified using a Talon affinity resin (Clontech) applied to a HiTrap SP High Performance column (GE Healthcare). The final yield of purified U-13 C, 15 N protein (. 98% homogeneous by SDS-PAGE; 20.3 kDa by MALDI-TOF mass spectrometry) was ,25 mg/L. In addition, a U-15 N and 5% biosynthetically directed fractionally 13 C-labeled sample [21] was generated for stereo-specific assignment of isopropyl methyl groups. NMR samples were prepared at 0.7 mM protein concentration. An isotropic overall rotational correlation time of ,10 ns was inferred from 15 N spin relaxation times indicating that hMcl-1(171-327) is monomeric in solution.
NMR spectroscopy
NMR spectra were recorded at 25uC. Five G-matrix Fourier transform (GFT) NMR experiments [22] , [23] 13 C-labeled sample on a Varian INOVA 600 MHz spectrometer equipped with a cryogenic probe as was described [21] , [26] . Spectra were processed and analyzed using the programs NMRPipe [27] and XEASY [28] ). Furthermore, 100%/100% of Val and Leu isopropyl moieties with non-degenerate proton chemical shifts were stereospecifically assigned (Table 1) . Chemical shifts were deposited in the BioMagResBank [30] (accession code 19654).
1 H-1 H upper distance limit constraints for structure calculations were obtained from NOESY (Table 1 ). In addition, backbone dihedral angle constraints were derived from chemical shifts using the program TALOS [31] for residues located in well-defined secondary structure elements (Table 1 ). The programs CYANA [32] , [33] and AUTOSTRUCTURE [34] were used in parallel to assign long-range NOEs [24] . The final structure calculations were c performed using CYANA followed by explicit water bath refinement using the program CNS [35] .
